BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Qian Y, Wang X, Chen X. Inhibitors of glucose transport and glycolysis as novel anticancer therapeutics. World J Transl Med 2014; 3(2): 37-57 [DOI: 10.5528/wjtm.v3.i2.37]
URL: https://www.wjgnet.com/2220-6132/full/v3/i2/37.htm
Number Citing Articles
1
Byoung Hyuck Kim, Ji Hyun Chang. Differential effect of GLUT1 overexpression on survival and tumor immune microenvironment of human papilloma virus type 16-positive and -negative cervical cancerScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49928-x
2
Pratik Shriwas, Dennis Roberts, Yunsheng Li, Liyi Wang, Yanrong Qian, Stephen Bergmeier, Jennifer Hines, Subhodip Adhicary, Corinne Nielsen, Xiaozhuo Chen. A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolismCancer & Metabolism 2021; 9(1) doi: 10.1186/s40170-021-00248-7
3
Nada Oršolić, Maja Jazvinšćak Jembrek. Molecular and Cellular Mechanisms of Propolis and Its Polyphenolic Compounds against CancerInternational Journal of Molecular Sciences 2022; 23(18): 10479 doi: 10.3390/ijms231810479
4
Mahsa Eshkevar Vakili, Fateme Nezhad Shah Mohammadi, Mohammad Reza Ataollahi, Keivan Shams, Kari K. Eklund, Gholamreza Daryabor, Kurosh Kalantar. Targeting T Cell Metabolism as a Novel Approach for Treatment of MS: With a Focus on PFKFB3 InhibitorsEndocrine, Metabolic & Immune Disorders - Drug Targets 2023; 23(4): 417 doi: 10.2174/1871530322666220921160930
5
Martin K. Bakht, Jessica M. Lovnicki, Janice Tubman, Keith F. Stringer, Jonathan Chiaramonte, Michael R. Reynolds, Iulian Derecichei, Rosa-Maria Ferraiuolo, Bre-Anne Fifield, Dorota Lubanska, So Won Oh, Gi Jeong Cheon, Cheol Kwak, Chang Wook Jeong, Keon Wook Kang, John F. Trant, Colm Morrissey, Ilsa M. Coleman, Yuzhuo Wang, Hojjat Ahmadzadehfar, Xuesen Dong, Lisa A. Porter. Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for 18F-FDG Imaging of PSMA-Suppressed TumorsJournal of Nuclear Medicine 2020; 61(6): 904 doi: 10.2967/jnumed.119.231068
6
Zufeng Guo, Zhiqiang Cheng, Jingxin Wang, Wukun Liu, Hanjing Peng, Yuefan Wang, A. V. Subba Rao, Ruo‐jing Li, Xue Ying, Preethi Korangath, Maria V. Liberti, Yingjun Li, Yongmei Xie, Sam Y. Hong, Cordelia Schiene‐Fischer, Gunter Fischer, Jason W. Locasale, Saraswati Sukumar, Heng Zhu, Jun O. Liu. Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D MicroarraysAngewandte Chemie International Edition 2019; 58(48): 17158 doi: 10.1002/anie.201905578
7
Shabnam Heydarzadeh, Ali Asghar Moshtaghie, Maryam Daneshpour, Mehdi Hedayati. Hypothyroidism - New Aspects of an Old Disease2022;  doi: 10.5772/intechopen.101937
8
Narayan Sugandha, Lovika Mittal, Amit Awasthi, Shailendra Asthana. Cancer Cell Metabolism: A Potential Target for Cancer Therapy2020; : 103 doi: 10.1007/978-981-15-1991-8_8
9
Pratik Shriwas, Xiaozhuo Chen, A. Douglas Kinghorn, Yulin Ren. Plant‐derived glucose transport inhibitors with potential antitumor activityPhytotherapy Research 2020; 34(5): 1027 doi: 10.1002/ptr.6587
10
Hamid Aria, Marzieh Rezaei, Shima Nazem, Abdolreza Daraei, Ghasem Nikfar, Behnam Mansoori, Maryam Bahmanyar, Alireza Tavassoli, Mohammad Kazem Vakil, Yaser Mansoori. Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistanceFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.947885
11
Kapil Kumar Goel, Pramod Rawat, Yogesh Murti, Shriya Mahajan, Harsimrat Kandhari, Bhupinder Kumar, Ashish Ranjan Dwivedi. Investigating Therapies Targeting Druggable Targets of Mitochondria: Exploring the Efficacy for the Treatment of CancerChemistrySelect 2024; 9(34) doi: 10.1002/slct.202401707
12
Tomoyuki Furuta, Yuya Mizukami, Lisa Asano, Kenjiro Kotake, Slava Ziegler, Hiroki Yoshida, Mizuki Watanabe, Shin-ichi Sato, Herbert Waldmann, Makiya Nishikawa, Motonari Uesugi. Nutrient-Based Chemical Library as a Source of Energy Metabolism ModulatorsACS Chemical Biology 2019; 14(9): 1860 doi: 10.1021/acschembio.9b00444
13
Farzaneh Beygi, Azar Mostoufi, Ayyub Mojaddami. Novel Hydrazone Derivatives of 3‐Bromopyruvate: Synthesis, Evaluation of the Cytotoxic Effects, Molecular Docking and ADME StudiesChemistry & Biodiversity 2022; 19(6) doi: 10.1002/cbdv.202100754
14
Lynne W. Elmore, Susanna F. Greer, Elvan C. Daniels, Charles C. Saxe, Michael H. Melner, Ginger M. Krawiec, William G. Cance, William C. Phelps. Blueprint for cancer research: Critical gaps and opportunitiesCA: A Cancer Journal for Clinicians 2021; 71(2): 107 doi: 10.3322/caac.21652
15
Yulin Ren, Qingwei Tan, Kimberly Heath, Sijin Wu, James R. Wilson, Jinhong Ren, Pratik Shriwas, Chunhua Yuan, Tran Ngoc Ninh, Hee-Byung Chai, Xiaozhuo Chen, Djaja D. Soejarto, Michael E. Johnson, Xiaolin Cheng, Joanna E. Burdette, A. Douglas Kinghorn. Cytotoxic and non-cytotoxic cardiac glycosides isolated from the combined flowers, leaves, and twigs of Streblus asperBioorganic & Medicinal Chemistry 2020; 28(4): 115301 doi: 10.1016/j.bmc.2019.115301
16
Yulin Ren, Hennrique T. Ribas, Kimberly Heath, Sijin Wu, Jinhong Ren, Pratik Shriwas, Xiaozhuo Chen, Michael E. Johnson, Xiaolin Cheng, Joanna E. Burdette, A. Douglas Kinghorn. Na+/K+-ATPase-Targeted Cytotoxicity of (+)-Digoxin and Several Semisynthetic DerivativesJournal of Natural Products 2020; 83(3): 638 doi: 10.1021/acs.jnatprod.9b01060
17
Ana M. Barbosa, Fátima Martel. Targeting Glucose Transporters for Breast Cancer Therapy: The Effect of Natural and Synthetic CompoundsCancers 2020; 12(1): 154 doi: 10.3390/cancers12010154
18
Anna Choromańska, Jolanta Saczko, Sandra Łubińska, Anna Szewczyk, Julita Kulbacka. WITHDRAWN: Mechanisms of antimelanoma effect of oat β-glucan supported by electroporationBioelectrochemistry 2018;  doi: 10.1016/j.bioelechem.2018.01.003
19
Shabnam Heydarzadeh, Ali Asghar Moshtaghie, Maryam Daneshpoor, Mehdi Hedayati. Regulators of glucose uptake in thyroid cancer cell linesCell Communication and Signaling 2020; 18(1) doi: 10.1186/s12964-020-00586-x
20
Hweixian Leong Penny, Je Lin Sieow, Sin Yee Gun, Mai Chan Lau, Bernett Lee, Jasmine Tan, Cindy Phua, Florida Toh, Yvonne Nga, Wei Hseun Yeap, Baptiste Janela, Dilip Kumar, Hao Chen, Joe Yeong, Justin A. Kenkel, Angela Pang, Diana Lim, Han Chong Toh, Tony Lim Kiat Hon, Christopher I. Johnson, Hanif Javanmard Khameneh, Alessandra Mortellaro, Edgar G. Engleman, Olaf Rotzschke, Florent Ginhoux, Jean-Pierre Abastado, Jinmiao Chen, Siew Cheng Wong. Targeting Glycolysis in Macrophages Confers Protection Against Pancreatic Ductal AdenocarcinomaInternational Journal of Molecular Sciences 2021; 22(12): 6350 doi: 10.3390/ijms22126350
21
Daniel R. Schmidt, Rutulkumar Patel, David G. Kirsch, Caroline A. Lewis, Matthew G. Vander Heiden, Jason W. Locasale. Metabolomics in cancer research and emerging applications in clinical oncologyCA: A Cancer Journal for Clinicians 2021; 71(4): 333 doi: 10.3322/caac.21670
22
Monika Pliszka, Leszek Szablewski. Glucose Transporters as a Target for Anticancer TherapyCancers 2021; 13(16): 4184 doi: 10.3390/cancers13164184
23
Vasilij Koshkin, Laurie E. Ailles, Geoffrey Liu, Sergey N. Krylov. Metabolic Suppression of a Drug‐Resistant Subpopulation in Cancer Spheroid CellsJournal of Cellular Biochemistry 2016; 117(1): 59 doi: 10.1002/jcb.25247
24
Zufeng Guo, Zhiqiang Cheng, Jingxin Wang, Wukun Liu, Hanjing Peng, Yuefan Wang, A. V. Subba Rao, Ruo‐jing Li, Xue Ying, Preethi Korangath, Maria V. Liberti, Yingjun Li, Yongmei Xie, Sam Y. Hong, Cordelia Schiene‐Fischer, Gunter Fischer, Jason W. Locasale, Saraswati Sukumar, Heng Zhu, Jun O. Liu. Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D MicroarraysAngewandte Chemie 2019; 131(48): 17318 doi: 10.1002/ange.201905578
25
Jayashis Dasgupta, Avirup Malla, Suvroma Gupta, Runa Sur. In Silico Screening of Sulfonamide Derivatives against Glycolytic Enzymes Reveals Mutation‐Independent Interactions of Sulfisoxazole and SulfamethazineChemistrySelect 2024; 9(36) doi: 10.1002/slct.202402572
26
Beatriz Bueschbell, Ana Beatriz Caniceiro, Pedro M.S. Suzano, Miguel Machuqueiro, Nícia Rosário-Ferreira, Irina S. Moreira. Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancerDrug Resistance Updates 2022; 60: 100811 doi: 10.1016/j.drup.2022.100811
27
Subodh Kumar, Gitika Batra, Seema Bansal, Praisy K. Prabha, Hardeep Kaur, Ajay Prakash, Anurag Kuhad, Bikash Medhi. Biomarkers in Cancer Detection and Monitoring of Therapeutics2024; : 297 doi: 10.1016/B978-0-323-95116-6.00016-5
28
Sindhuri Pragallapati, Ravikanth Manyam. Glucose transporter 1 in health and diseaseJournal of Oral and Maxillofacial Pathology 2019; 23(3): 443 doi: 10.4103/jomfp.JOMFP_22_18
29
Izabela Nawrot-Hadzik, Adam Matkowski, Magdalena Fast, Anna Choromańska. The combination of pro-oxidative acting vanicosides and GLUT1 inhibitor (WZB117) exerts a synergistic cytotoxic effect against melanoma cellsFitoterapia 2023; 171: 105702 doi: 10.1016/j.fitote.2023.105702
30
Kalpana Tilekar, Neha Upadhyay, Cristina V. Iancu, Vadim Pokrovsky, Jun-yong Choe, C.S. Ramaa. Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188457 doi: 10.1016/j.bbcan.2020.188457
31
Ana S. Nunes, Andreia S. Barros, Elisabete C. Costa, André F. Moreira, Ilídio J. Correia. 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugsBiotechnology and Bioengineering 2019; 116(1): 206 doi: 10.1002/bit.26845
32
Yu-Liang Li, Hao-Cheng Weng, Jui-Ling Hsu, Shu-Wha Lin, Jih-Hwa Guh, Lih-Ching Hsu. The Combination of MK-2206 and WZB117 Exerts a Synergistic Cytotoxic Effect Against Breast Cancer CellsFrontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.01311
33
Sindhuri Pragallapati, Ravikanth Manyam. Glucose transporter 1 expression in ameloblastoma and odontogenic keratocyst – A comparative immunohistochemical studyJournal of Oral and Maxillofacial Pathology 2022; 26(2): 185 doi: 10.4103/jomfp.jomfp_9_21